116094-23-6
| Pack Size | Price | Stock | Quantity |
| 25mg | RMB1392.00 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| solubility | Practically insoluble in ethanol (96 per cent), in methanol and in aqueous solutions with a pH around 5.1. In aqueous solutions below pH 3.5 or above pH 6.5, the solubility is greater than or equal to 25 mg/mL. |
| form | Liquid |
| color | Colorless to light yellow |
| Major Application | USP Biologics pharmaceutical (small molecule) pharmaceutical |
Description and Uses
Insulin Aspart is a rapid-acting insulin analog produced by recombinant DNA technology. It differs structurally from human insulin in that aspartic acid replaces the original proline at position 28 of the B chain.This modification allows for improved postprandial glucose control in diabetic patients. The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.
Insulin aspart is used to treat diabetes mellitus and is manufactured by Novo Nordisk under the trade name NovoRapid. It is a recombinant, biosynthetic, fast-acting insulin analogue that helps control blood glucose levels in patients with type 1 and type 2 diabetes mellitus. It has a single amino acid substitution at position B28, where proline is replaced with aspartic acid.
Safety
| WGK Germany | WGK 3 |
| HS Code | 2937120000 |
| Storage Class | 11 - Combustible Solids |
